Medical Cannabis Advocacy in South Asia During the 1930s

The 1894 Report as Historical Anchor

By the 1930s, cannabis had been used medicinally across South Asia for centuries in Ayurvedic, Unani, and folk traditions. Western medical interest began after William O'Shaughnessy's 1839 experiments in Calcutta and led to cannabis tinctures and extracts entering the Pharmacopoeia of India ^[1].

The intellectual foundation for 1930s-era Indian defence of cannabis was the Indian Hemp Drugs Commission Report of 1894. This seven-volume inquiry, commissioned by the British Raj, concluded that moderate use of cannabis caused no significant physical, mental, or moral harm and that prohibition would be unjustifiable and unenforceable ^[2] Strong evidence. The report became India's primary rhetorical tool in later policy debates.

Throughout the interwar period, cannabis remained legally available under a provincial excise system, and Indian physicians continued to prescribe cannabis preparations. However, the 1894 Report itself was not re-examined or revalidated during the 1930s; it was cited defensively as received authority rather than as a basis for new investigation Strong evidence.

International Control Efforts: The Geneva Framework, 1924–1935

The pivotal policy battles occurred not in Delhi but in Geneva, where cannabis became a matter of international treaty negotiation.

At the Second Opium Conference (1924–1925), the Egyptian delegate Mohamed El Guindy advocated for adding cannabis (specifically hashish) to international drug control regimes. India's representation at these negotiations centred on defending the right to maintain domestic medical and cultural use Strong evidence.

The outcome was the 1925 Geneva Convention on narcotics, which placed Indian hemp under international control for export purposes but permitted member states to regulate domestic use, including for medical purposes. This represented a compromise: India retained regulatory authority over its domestic excise system, but the principle of international control over cannabis was established.

Throughout the 1930s, the League of Nations Advisory Committee on Traffic in Opium and Other Dangerous Drugs continued to press for tighter cannabis restrictions. India's official representatives repeatedly submitted reports defending the provincial excise model as a regulated middle path between prohibition and unrestricted commerce, citing the 1894 Commission as justification Strong evidence. However, these arguments represented continuation of existing policy rather than successful reversal of the international control trajectory.

Domestic Medical and Traditional Voices

Within India, professional opinion on cannabis was diverse but not unified into a coherent advocacy movement.

The Indian Medical Service, staffed primarily by British-trained physicians, maintained cannabis preparations (tincture of cannabis, extractum cannabis indicae) in official formularies throughout the 1930s ^[4]. Individual physicians published clinical case reports and pharmacological observations in journals like the Indian Medical Gazette ^[5]. However, there is no evidence of organized professional opposition to international control efforts.

Ayurvedic and Unani practitioners defended vijaya (Sanskrit for cannabis) and bhang as traditional remedies for digestive complaints, insomnia, and chronic pain Weak / limited. Cannabis was incorporated into broader Ayurvedic revivalist arguments for the legitimacy of indigenous medicine during this period. Sufi and Shaiva religious communities also defended ritual and spiritual use of cannabis-based preparations. Yet these voices operated separately from medical-professional discourse and lacked the institutional leverage of government or colonial officials Weak / limited.

No organized 'cannabis advocacy movement' in the modern sense existed. What occurred was a loose alignment of interests: colonial excise departments defending revenue; medical practitioners defending pharmacopoeial inclusion; and traditional communities defending cultural and spiritual practice.

The Revenue Foundation of Policy

A crucial but often understated factor in India's defensive posture toward cannabis was financial: provincial governments in Bengal, the United Provinces, and Bombay Presidency collected substantial excise revenue from licensed ganja and bhang retail operations. This revenue stream was material to provincial budgets during the 1930s Strong evidence.

Internal Government of India correspondence from the decade repeatedly weighed the medical and cultural arguments for cannabis against the fiscal impact of prohibition Strong evidence. Government of India reports to the League of Nations Advisory Committee defended the domestic excise system, but private official communications reveal that revenue protection was a primary concern.

This is not to suggest that medical arguments were insincere—practitioners did believe in therapeutic value—but the coalition defending cannabis included excise officials and treasury representatives whose primary motivation was fiscal rather than therapeutic. Medical legitimacy provided a rhetorical shield for a fundamentally revenue-driven policy.

Myths About 1930s Cannabis Advocacy

Several popular narratives about 1930s South Asian cannabis advocacy overstate or misrepresent the historical record:

Myth: India single-handedly prevented international cannabis prohibition. Reality: India negotiated for exemptions and secured partial ones under the 1925 Geneva Convention, but the overall trajectory of international control advanced throughout the decade. India was one voice among many at the League of Nations, and by 1939 the momentum toward global prohibition was unmistakable Disputed.

Myth: The 1894 Hemp Drugs Commission Report was comprehensively revalidated in the 1930s. Reality: The Commission was repeatedly cited by Indian officials, but no new scientific review or public inquiry was undertaken. India's 1930s position was defensive invocation of a 40-year-old document rather than reexamination of its findings Strong evidence.

Myth: Ayurvedic practitioners led organized professional resistance to cannabis control. Reality: Ayurvedic revivalism was a real intellectual and political current in 1930s India, but cannabis was peripheral to it. The loudest institutional defenders of cannabis were colonial excise officials and Indian Medical Service pharmacists, not traditional medicine practitioners Weak / limited.

Myth: Mahatma Gandhi supported medical cannabis. No credible primary historical source supports this claim. Gandhi's publicly documented views on intoxicants and narcotics were restrictive. This assertion appears to be modern invention without basis in contemporary records No data.

Outcome and Legacy

By the end of the 1930s, cannabis remained legally available in India under provincial excise regulation, and tincture of cannabis was still listed in Indian and British pharmacopoeias. Indian officials had delayed but not prevented the advance of international control.

The 1930s debates foreshadowed cannabis's later trajectory: despite documented medical use, demonstrated cultural significance, and government-sanctioned regulatory frameworks, international drug-control regimes advanced. India's position substantially eroded over subsequent decades. The 1961 Single Convention on Narcotic Drugs classified cannabis as a schedule IV drug, and India's Narcotic Drugs and Psychotropic Substances Act of 1985 finally implemented those provisions domestically, effectively ending the excise system that had survived since colonial times ^[6].

For modern readers, the 1930s South Asian experience is instructive: it demonstrates that even a large, well-documented tradition of medical and cultural use, combined with government willingness to defend that use, proved insufficient to withstand international prohibition regimes. Neither evidence nor tradition could overcome the momentum of global drug control.

Sources

How this page was made

Related

• 1961 Single Convention on Narcotic Drugs — The UN treaty that unified international drug control and shaped cannabis prohibition glob...
• Cannabis Activism in East Asia During the 1930s — Why organized cannabis activism was nearly absent in 1930s East Asia, and what was actuall...
• Medical Cannabis Advocacy in South America During the 1910s — Medical cannabis existed quietly in pharmacies; organized advocacy was absent in 1910s Sou...
• Medical Cannabis Advocacy in South America During the 1980s — No organized medical cannabis movement existed in South America during the 1980s despite l...
• UN Drug Treaties and Cannabis — Three UN treaties control cannabis globally; legalization exists despite treaty language f...